Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FTEDB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,422
Award facts
- Contract value 100% obligated
- $12,421.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,421.82 to AmerisourceBergen Drug Corp for the supply of KEVZARA 200 mg/1.14 mL pen injections. This competitive, firm fixed-price delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. KEVZARA (sarilumab) is a biologic immunosuppressant used in the treatment of rheumatoid arthritis, representing a specialized pharmaceutical product within the contractor's broader medical supply portfolio.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and prime vendor to federal military and veteran healthcare systems, AmerisourceBergen Drug Corp leverages this comprehensive contract vehicle to supply brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare programs worldwide. The award reflects the contractor's established capability to meet federal procurement requirements through open competition and demonstrates the DLA's reliance on established prime vendors for critical pharmaceutical supply chain support.
Quick answers
Who was awarded contract SPE2DB25FTEDB?
SPE2DB25FTEDB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FTEDB worth?
The government has obligated $12,422 on SPE2DB25FTEDB.
Is contract SPE2DB25FTEDB an order under another contract?
Yes. SPE2DB25FTEDB is a delivery order under SPE2DB25D3110, an indefinite delivery contract.
Was contract SPE2DB25FTEDB competed?
The extent of competition for SPE2DB25FTEDB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award